List view / Grid view
18 April 2019 | By European Pharmaceutical Review
According to a new report, regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) regimens.
18 April 2019 | By Nikki Withers (European Pharmaceutical Review)
The grant will support African trials of a novel antimalarial combination comprising KAF156 (ganaplacide) and lumefantrine in a new once-daily formulation...
1 April 2019 | By European Pharmaceutical Review
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial...
28 March 2019 | By European Pharmaceutical Review
In a ruling handed down on 27 March 2019 by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be rewarded with a patent...
25 March 2019 | By European Pharmaceutical Review
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer...
19 March 2019 | By Iqra Farooq
As Dr Scott Gottlieb steps down from his role next month, Dr Ned Sharpless has been announced as his short-term replacement...
18 March 2019 | By European Pharmaceutical Review
An absorbable antibiotic envelope could cut the number of cardiac infections after surgery to implant or replace cardioverter defibrillators and pacemakers...
14 March 2019 | By Iqra Farooq
Cablivi and Egaten were the two top novel drugs approved last month, with a focus on parasitic infestation and the rare disorder, aTTP...
6 March 2019 | By European Pharmaceutical Review
Researchers have identified a possible association between use of statins and developing type 2 diabetes after following patients for 15 years...
27 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A New Drug Application has been made to the US Food and Drug Administration for the drug darolutamide to treat non-metastatic prostate cancer...
25 February 2019 | By European Pharmaceutical Review
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
22 February 2019 | By Nikki Withers (European Pharmaceutical Review)
US researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data using blockchain...
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
21 February 2019 | By European Pharmaceutical Review
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
20 February 2019 | By European Pharmaceutical Review
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
Follow: